Coinbase CEO and BlakeByers are teaming up to create NewLimit, a new company that aims to promote human health.

On December 12, Coinbase CEO Brian Armstrong announced that he would form NewLimit, a new company with the aim of developing human health with Blake Byers. Starting with an in-depth study of the epigenetic factors of aging, NewLimit will develop products capable of stimulating tissue therapy to treat specific patients. NewLimit says it will first develop technology to study age-related changes in chromatid-mediated devices using the human brain and its uses. Or do it another way. NewLimit initially raised $ 105 million from the developer to help build the business, and said additional funding would follow. We do not expect investments to be limited over the next few years. In the future, external funding may also exist. In addition to funding and board work, Blake Byers and Brian Armstrong are currently interviewing and recruiting for the design team. The initial team consisted of members of the scientists, clinics and the working group.